Biopharma
A 'poster child' for Chinese biopharma wins US approval for new cancer therapy
This approval provides a vital new option for US patients with advanced nasopharyngeal carcinoma and validates the quality of our innovation said Dr Xia Yu founder and chief executive of Zhongshan...
3d